Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 10, 2006, Pages 678-681

  Thorell, Emily A ^a   Sharma, Mukta ^b   Jackson, Mary Anne ^b   Selvarangan, Rangaraj ^b   Woods, Gerald M ^b  

^a CHILDREN S MERCY HOSPITAL   (United States)

^b NONE

Author keywords

Hydroxyurea; Mycobacterium fortuitum; Nontuberculous mycobacteria; Pulmonary disease; Sickle cell

Indexed keywords

AMIKACIN; ANALGESIC AGENT; ASPARTATE AMINOTRANSFERASE; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; GATIFLOXACIN; HYDROXYUREA; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN DERIVATIVE; SULFAMETHOXAZOLE;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CULTURE; BONE MARROW SUPPRESSION; CASE REPORT; CELLULAR IMMUNODEFICIENCY; CENTRAL VENOUS CATHETER; CRYPTOSPORIDIOSIS; DISTRESS SYNDROME; FEMALE; FEVER; GRAM NEGATIVE INFECTION; HEMOGLOBINOPATHY; HEPATOSPLENOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LEUKEMIA; LUNG ABSCESS; LUNG INFILTRATE; LYMPHADENOPATHY; LYMPHOCYTOPENIA; MYCOBACTERIOSIS; MYCOBACTERIUM FORTUITUM; NEUTROPENIA; PERICARDIAL EFFUSION; PLESIOMONAS SHIGELLOIDES; PLEURA EFFUSION; PRIORITY JOURNAL; SEPSIS; SICKLE CELL ANEMIA; SIDE EFFECT; SKIN ULCER; SYSTOLIC HEART MURMUR; TACHYPNEA; THORAX PAIN; THROMBOCYTOPENIA; THROMBOCYTOSIS; TREATMENT DURATION;

ACETAMIDES; ADOLESCENT; AMIKACIN; ANEMIA, SICKLE CELL; ANTI-BACTERIAL AGENTS; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYUREA; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS; OXAZOLIDINONES; TREATMENT OUTCOME;

EID: 33749580287     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000243646.59111.28     Document Type: Article

References (24)

1. Cross JT, Jacobs RF. Other mycobacteria. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Disease. 4th ed. Philadelphia: WB Saunders Company; 1998:1239-1248.
2. Raad II, Vartivarian S, Khan A, et al. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis. 1991;13:1120-1125.
3. Wallace RJ, Swenson JM, Silcox VA, et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5:657-679.
4. Suryanarayan K, Campbell J, Eskanazi AE. Nontuberculous mycobacterial infections in pediatric acute leukemia. J Pediatr Hematol Oncol. 2002;24:558-560.
5. Reilly AF, McGowan KL. Atypical mycobacterial infections in children with cancer. Pediatr Blood Cancer. 2004;43:698-702.
6. Davidson RN, Wall RA. Prevention and management of infections in patients without a spleen. Clin Microbiol Infect. 2001;7:657-660.
7. Blei F, Puder DR. Yersenia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature. Am J Pediatr Hematol Oncol. 1993;15:430-434.
8. Lion C, Escande F, Burdin JC. Capnocytophaga canimorsus infections in human: review of the literature and cases report. Eur J Epidemiol. 1996;12:521-533.
9. Jeng MR, Feusner J, Skibola C, et al. Central venous catheter complications in sickle cell disease. Am J Hematol. 2002;69:103-108.
10. Abdul-Rauf A, Gauderer M, Chiarucci K, et al. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications. J Pediatr Hematol Oncol. 1995;17:342-345.
11. Raj A, Bertolone S, Bond S, et al. Cathlink(R) 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis - a report of low complication rates. Pediatr Blood Cancer. 2005;44:669-672.
12. Swanson DS. Central venous catheter-related infections due to nontuberculous mycobacterium species. Pediatr Infect Dis J. 1998;17:1163-1164.
13. Rodgers GL, Mortensen JE, Blecker-Shelly D, et al. Two case reports and review of vascular catheter-associated bacteremia caused by nontuberculous mycobacterium species. Pediatr Infect Dis J. 1996;15:260-264.
14. Gaviria JM, Garcia PJ, Garrido SM, et al. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant. 2000;6:361-369.
15. Levendoglu-Tugal O, Munoz J, Brudnicki A, et al. Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis. 1998;5:1227-1230.
16. Suara R, Whitlock J, Spearman P. Mycobacteria fortuitum central venous catheter-related bacteremia in an infant with renal sarcoma. Pediatr Hematol Oncol. 2001;18:363-365.
17. Brady MT, Marcon MJ, Maddux H. Broviac catheter-related infection due to Mycobacterium fortuitum in a patient with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1987;6:492-494.
18. Primm TP, Lucero CA, Falkinham JO III. Health impacts of environmental bacteria. Clin Microbiol Rev. 2004;17:98-106.
19. Galassi L, Donato R, Tortoli E, et al. Nontuberculous mycobacteria in hospital water systems: application of HPLC for identification of environmental mycobacteria. J Water Health. 2003;1:133-139.
20. Hoyt L, Oleske J, Holland B, et al. Nontuberculous mycobacteria in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1992;11:354-360.
21. Ware R, Zimmerman S, Schultz W. Hydroxyurea as an alternative to blood transfusions for the prevention of recurrent stroke in children with sickle cell disease. Blood. 1999;94:3022-3026.
22. Wang WC, Wynn LW, Rogers ZR, et al. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr. 2001;139:790-796.
23. Tzanetea R, Konstantopoulas K, Xanthaki A, et al. Plesiomonas shigelloides sepsis in a thalassemia intermedia patient. Scand J Infect Dis. 2002;34:687-689.
24. Venigalla P, Motwani B, Allen S, et al. A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection. Blood. 2002;100:363.